LSL Pharma Group Inc. (TSXV:LSL)
Canada · Delayed Price · Currency is CAD 0.3750
+0.0150 (4.17%)
Oct 23, 2025, 3:21 PM EDT
LSL Pharma Group Market Cap
LSL Pharma Group has a market cap or net worth of CAD 45.46 million as of October 24, 2025. Its market cap has decreased by -11.58% in one year.
Market Cap
45.46M
Enterprise Value
68.59M
Revenue
23.24M
Ranking
n/a
PE Ratio
12.14
Stock Price
0.38
Market Cap Chart
Since March 2, 2023, LSL Pharma Group's market cap has decreased from 61.67M to 45.46M, a decrease of -26.29%. That is a compound annual growth rate of -10.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 45.46M | -4.03% |
| Dec 31, 2024 | 47.37M | 18.48% |
| Dec 29, 2023 | 39.98M | -35.17% |
| Mar 2, 2023 | 61.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.90B |
| Green Thumb Industries | 2.34B |
| dentalcorp Holdings | 2.17B |
| Trulieve Cannabis | 1.90B |
| Sienna Senior Living | 1.83B |
| Extendicare | 1.34B |
| Cronos Group | 1.29B |
| WELL Health Technologies | 1.26B |